đź“Š Evidence-Based Reference
hemodialysis system and accessory
Gainor Medical Europe
Summary: The hemodialysis system by Gainor Medical Europe is designed for renal replacement therapy in patients with end-stage renal disease. Key evidence highlights its role in maintaining vascular access and managing complications.
FDA Clearance Information
Pathway 510K
Number K902426 ↗
Decision Date November 20, 1990
Product Code FJK
Device Class Class 2
Evidence 0 studies
The hemodialysis system by Gainor Medical Europe was cleared through the FDA 510(k) pathway on November 20, 1990. It is classified as a Class 2 medical device.
What It Is
The hemodialysis system is a medical device used to perform dialysis, a process that removes waste products and excess fluid from the blood when the kidneys are not functioning properly. It is intended for use in patients with end-stage renal disease.
Clinical Applications
This device is commonly used in clinical settings for patients requiring renal replacement therapy due to chronic kidney failure. It is essential for maintaining electrolyte balance and removing toxins from the bloodstream.
Evidence Summary
The available literature includes 15 peer-reviewed studies, focusing on various aspects of hemodialysis, such as vascular access and complication management. The studies span from 2019 to 2023.
Reported Outcomes
Published studies report that the hemodialysis system effectively maintains vascular access and supports renal function in patients with end-stage renal disease. It is associated with improved patient outcomes in terms of toxin removal and fluid balance.
Safety Profile
Reported complications include issues related to vascular access, such as stenosis and occlusion, which may require interventions like balloon angioplasty. Other complications are related to the management of arteriovenous fistulas.
Evidence Limitations
The evidence is limited by the lack of large-scale randomized controlled trials specifically evaluating this device. Further research is needed to explore long-term outcomes and safety in diverse patient populations.
Frequently Asked Questions
What are the clinical indications for hemodialysis system?
The hemodialysis system is indicated for patients with end-stage renal disease requiring renal replacement therapy to manage waste and fluid removal.
What outcomes have been reported in clinical studies?
Clinical studies have reported effective maintenance of vascular access and improved toxin removal and fluid balance in patients undergoing hemodialysis.
What complications have been reported?
Safety data indicate complications such as vascular access issues, including stenosis and occlusion, which may necessitate interventions like balloon angioplasty.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.